Found 6 matching trials
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma PHASE2 The current study is an investigator-initiated, single-arm phase 2 study th...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of HR07080...
Show More Location
Multiple Locations
Learn More & Join Trial
HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer PHASE3 The purpose of this study is to look at the efficacy and safety of HR070803...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer PHASE2 This is a double-blind, randomized, multi-center, II/III study in at least ...
Show More Status
Active Not Recruiting
Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer PHASE2 To evaluate the efficacy, safety and pharmacokinetic characteristics of HR0...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer PHASE3 The purpose of this study is to look at the efficacy and safety of HR070803...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial